Skip to main content

Table 2 Comparison between sugammadex and neostigmine groups before and after propensity score-matching. Presented as n (%) or mean (SD)

From: Comparison of the effects of sugammadex and neostigmine on hospital stay in robot-assisted laparoscopic prostatectomy: a retrospective study

  Before propensity score-matching (n = 1430) ASD After propensity score-matching (n = 888) ASD
Sugammadex
(n = 924)
Neostigmine
(n = 506)
Sugammadex
(n = 444)
Neostigmine
(n = 444)
Age, year (≥65) 579 (62.7) 310 (61.3) 0.03 270 (60.8) 261 (58.8) 0.04
Body mass index, kg m−2 24.5 (2.7) 25.1 (7.7) 0.20 24.7 (2.7) 24.9 (6.2) 0.08
Charlson Comorbidity Index score 4.7 (1.2) 4.8 (1.2) 0.07 4 .8 (1.3) 4.8 (1.2) 0.06
ASA physical status
 1 302 (32.6) 184 (36.4)   159 (35.8) 151 (34.0)  
 2 554 (60.0) 289 (57.1) 0.05 255(57.4) 261 (58.8) 0.03
  ≥ 3 68 (7.4) 33 (6.5) 0.03 30 (6.8) 32 (7.2) 0.02
Intraoperative rocuronium dose, mg
  ≥ 50, and < 100 742 (80.2) 420 (82.8) 0.02 381 (85.8) 383 (86.3) 0.01
  ≥ 100 176 (19.0) 78 (15.4) 0.11 32 (7.2) 39 (8.8) 0.05
Intraoperative remifentanil dose, per 100 mcg (≥10) 76 (8.2) 112 (22.1) 0.52 62(14.0) 59 (13.3) 0.02
Total intravenous anesthesia 68(13.4) 38(4.1) 0.47 35(7.9) 29(6.5) 0.07
Duration of anesthesia, h 3.9 (0.7) 4.2 (0.8) 0.34 4.1 (0.8) 4.1 (0.7) 0.07
Estimated blood loss, L 0.15 (0.1) 0.19 (0.1) 0.25 0.2 (0.2) 0.2 (0.1) 0.08
Distance, kma
  ≥ 40, and < 180 44(8.7) 191(20.7) 0.29 44(9.9) 40(9.0) 0.02
 180≥ 20(2.0) 201(21.8) 0.43 20(4.5) 28(6.3) 0.04
Operation by skilled surgeonb 810 (87.6) 407 (80.3) 0.21 367 (82.7) 382 (860.) 0.10
  1. ASA American Society of Anesthesiologists, ASD absolute value of standardized mean difference
  2. Presented as n (%) or mean (standard deviation)
  3. a Distance means the distance between home and the hospital
  4. bSurgeons who had done robot-assisted laparoscopic prostatectomy more than 200 cases